Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug

ClinicalTrials.gov ID: NCT03104374

Public ClinicalTrials.gov record NCT03104374. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 3:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo in Subjects With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug (bDMARD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3 multicenter study that included two periods. Period 1 was designed to compare the safety, tolerability, and efficacy of upadacitinib 15 mg once daily (QD) and 30 mg QD versus placebo in participants with moderately to severely active Psoriatic Arthritis (PsA) who had an inadequate response to Biological Disease Modifying Anti-Rheumatic Drug (bDMARDs). Period 2 evaluated the safety, tolerability and efficacy of upadacitinib 15 mg QD and 30 mg QD in subjects with PsA who completed Period 1.

Study identification

NCT ID
NCT03104374
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
642 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1, 2017 (Actual)
Primary completion
Jul 23, 2019 (Actual)
Completion
Sep 30, 2024 (Actual)
Last update posted
Sep 11, 2025

2017 – 2024

United States locations

U.S. sites
72
U.S. states
26
U.S. cities
68
Facility City State ZIP Site status
Alabama Medical Group, PC /ID# 159836 Mobile Alabama 36608-1787 —
Arizona Arthritis & Rheumatology Research, PLLC /ID# 160047 Mesa Arizona 85210-6871 —
Sun Valley Arthritis Center Ltd. /ID# 161203 Peoria Arizona 85381 —
Duplicate_AZ Arthritis and Rheumotology Research, PLLC /ID# 160006 Phoenix Arizona 85032-9306 —
Osteoporosis Medical Center /ID# 161411 Beverly Hills California 90211 —
Covina Arthritis Clinic /ID# 159919 Covina California 91722 —
Triwest Research Associates /ID# 159915 El Cajon California 92020 —
Duplicate_Providence Medical Foundation /ID# 160005 Fullerton California 92835 —
C.V. Mehta MD, Med Corporation /ID# 161192 Hemet California 92543 —
Care Access Research, Huntington Beach /ID# 160049 Huntington Beach California 92648 —
Purushotham & Akther Kotha MD, Inc /ID# 159834 La Mesa California 91942 —
Stanford University School of Med /ID# 161402 Stanford California 94305-2200 —
Inland Rheum Clin Trials Inc. /ID# 159839 Upland California 91786 —
Medvin Clinical Research /ID# 160045 Whittier California 90606 —
Denver Arthritis Clinic /ID# 159899 Denver Colorado 80230 —
Colorado Arthritis Associates /ID# 159856 Lakewood Colorado 80228 —
Duplicate_Arthritis & Rheumatic Disease Specialties /ID# 161409 Aventura Florida 33180 —
International Medical Research /ID# 160051 Daytona Beach Florida 32117 —
Precision Research Organization /ID# 161293 Miami Lakes Florida 33016-1501 —
Duplicate_Suncoast Clinical Research /ID# 161417 New Port Richey Florida 34652 —
Millennium Research /ID# 159833 Ormond Beach Florida 32174 —
Arthritis Center, Inc. /ID# 163463 Palm Harbor Florida 34684 —
Gulf Region Clinical Res Inst /ID# 159860 Pensacola Florida 32514 —
Sarasota Arthritis Center /ID# 159854 Sarasota Florida 34239 —
BayCare Medical Group /ID# 161405 St. Petersburg Florida 33705 —
West Broward Rheumatology Associates /ID# 161412 Tamarac Florida 33321 —
Clinical Research of West Florida - Tampa /ID# 160069 Tampa Florida 33606-1246 —
Clinical Research of West Florida, Inc /ID# 159840 Tampa Florida 33606-1246 —
USF Health Morsani Center for /ID# 161291 Tampa Florida 33612 —
BayCare Medical Group, Inc. /ID# 159912 Tampa Florida 33614-7101 —
Florida Medical Clinic /ID# 160013 Zephyrhills Florida 33542 —
Jefrey D. Lieberman, MD, P.C. /ID# 159842 Decatur Georgia 30033 —
Atlanta Research Center for Rheumatology /ID# 161201 Marietta Georgia 20060 —
Velocity Clinical Research - Boise /ID# 159922 Meridian Idaho 83642 —
Great Lakes Clinical Trials /ID# 163438 Chicago Illinois 60640 —
Deerbrook Medical Associates /ID# 159815 Libertyville Illinois 60048 —
Duplicate_Clinic of Robert Hozman/Clinical Investigation Specialists /ID# 160068 Skokie Illinois 60076 —
The Arthritis & Diabetes Clinic, Inc. /ID# 161294 Monroe Louisiana 71203 —
Arthritis Treatment Center /ID# 160053 Frederick Maryland 21204 —
The Center for Rheumatology and Bone Research /ID# 159900 Wheaton Maryland 20902 —
Clinical Pharmacology Study Group /ID# 158712 Worcester Massachusetts 01605 —
Clinvest Research LLC /ID# 161208 Springfield Missouri 65807 —
Westroads Clinical Research /ID# 160004 Omaha Nebraska 68114 —
Atlantic Coast Research /ID# 159810 Toms River New Jersey 08755 —
Duplicate_Arthritis and Osteo Assoc /ID# 160015 Las Cruces New Mexico 88011 —
Center for Rheumatology LLP /ID# 167046 Albany New York 12203-3710 —
St. Lawrence Health System /ID# 159857 Potsdam New York 13676 —
DJL Clinical Research, PLLC /ID# 161414 Charlotte North Carolina 28211 —
Physicians East, PA /ID# 159898 Greenville North Carolina 27834 —
Shanahan Rheuma & Immuno /ID# 160012 Raleigh North Carolina 27617 —
PMG Research of Wilmington LLC /ID# 161403 Wilmington North Carolina 28401 —
Trinity Health Med Arts Clinic /ID# 159811 Minot North Dakota 58701 —
STAT Research, Inc. /ID# 161416 Vandalia Ohio 45377-9464 —
Health Research of Oklahoma /ID# 159913 Oklahoma City Oklahoma 73103-2400 —
Altoona Ctr Clinical Res /ID# 159861 Duncansville Pennsylvania 16635 —
University of Pittsburgh MC /ID# 161193 Pittsburgh Pennsylvania 15260 —
Articularis Healthcare Group, Inc d/b/a Low Country Rheumatology /ID# 163462 Summerville South Carolina 29486-7887 —
Rheumatology Consultants, PLLC /ID# 161408 Knoxville Tennessee 37909 —
Dr. Ramesh Gupta /ID# 160067 Memphis Tennessee 38119 —
Tekton Research, Inc. /ID# 160008 Austin Texas 78745 —
Diagnostic Group /ID# 161406 Beaumont Texas 77701 —
Arthritis and Osteoporosis Clinic Of Brazos Valley /ID# 163439 College Station Texas 77845 —
Adriana Pop-Moody MD Clinic PA /ID# 160009 Corpus Christi Texas 78404 —
Metroplex Clinical Research /ID# 159818 Dallas Texas 75231 —
Rheumatic Disease Clin Res Ctr /ID# 161252 Houston Texas 77004 —
Accurate Clinical Research /ID# 160052 Houston Texas 77089 —
P&I Clinical Research /ID# 159837 Lufkin Texas 75904-3132 —
SW Rheumatology Res. LLC /ID# 160014 Mesquite Texas 75150 —
DM Clinical Research - Tomball /ID# 161753 Tomball Texas 77375 —
Arthritis & Osteoporosis Clinic /ID# 161400 Waco Texas 76710 —
Arthritis Clinic of N. VA, P.C /ID# 159858 Arlington Virginia 22205 —
Duplicate_Swedish Medical Center /ID# 159918 Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 93 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03104374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2025 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03104374 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →